Related Experiment Video
Updated: Aug 21, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Hidradenitis suppurativa
1Division of Dermatology, Department of Medicine, Roskilde Hospital, Roskilde, Denmark. ccc2845@vip.cybercity.dk
Background:
Hidradenitis suppurativa is a clinically defined disease that causes considerable morbidity for patients. The results of recent studies, which have increased the understanding of this disease, are reviewed.
Objective:
The epidemiology, risk factors, pathogenesis, and treatment of this disease are summarized to help clinicians with practical patient management.
Conclusion:
Hidradenitis suppurativa remains a clinical challenge to patients and physicians alike. Physicians should be familiar with the impact this disease has on the patient and with the range of treatments available. Use of simple incisions as treatment is strongly discouraged. Additional pathogenic as well as therapeutic studies are necessary.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Acute Pyelonephritis I: Introduction
Staphylococcal Skin Infections
Acne Infection
Inflammatory Bowel Disease III: Crohn's Disease
Cirrhosis I: Introduction

